| 1 |
Chakrabarty N, Mahajan A, Prabhash K, Patil P, Chowhan M, Munmmudi N, Niyogi D, Dabkara D, Singh S, Singh A, Devarmani S, Dhull VS. Imaging Recommendations for Diagnosis, Staging, and Management of Esophageal Cancer. Indian J Med Paediatr Oncol 2023. [DOI: 10.1055/s-0042-1760324] [Reference Citation Analysis]
|
| 2 |
Liu H, Meng J. Comparison of LNM and survival in T1 stage esophageal cancer patients based on histological classification: A large population-based study. Medicine (Baltimore) 2022;101:e32143. [PMID: 36595761 DOI: 10.1097/MD.0000000000032143] [Reference Citation Analysis]
|
| 3 |
Wadhwa V, Patel N, Grover D, Ali FS, Thosani N. Interventional gastroenterology in oncology. CA A Cancer J Clinicians 2022. [DOI: 10.3322/caac.21766] [Reference Citation Analysis]
|
| 4 |
Zhang W, Luo J, Xiao Z, Zang Y, Li X, Zhou Y, Zhou J, Tian Z, Zhu J, Zhao X. USP36 facilitates esophageal squamous carcinoma progression via stabilizing YAP. Cell Death Dis 2022;13:1021. [PMID: 36470870 DOI: 10.1038/s41419-022-05474-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Zheng YH, Zhao EH. Recent advances in multidisciplinary therapy for adenocarcinoma of the esophagus and esophagogastric junction. World J Gastroenterol 2022; 28(31): 4299-4309 [DOI: 10.3748/wjg.v28.i31.4299] [Reference Citation Analysis]
|
| 6 |
He Y, Hua R, Yang Y, Li B, Guo X, Li Z. LncRNA JPX Promotes Esophageal Squamous Cell Carcinoma Progression by Targeting miR-516b-5p/VEGFA Axis. Cancers (Basel) 2022;14:2713. [PMID: 35681693 DOI: 10.3390/cancers14112713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Wichmann D, Fusco S, Werner CR, Voesch S, Duckworth-Mothes B, Schweizer U, Stüker D, Königsrainer A, Thiel K, Quante M. Endoscopic Management for Post-Surgical Complications after Resection of Esophageal Cancer. Cancers (Basel) 2022;14:980. [PMID: 35205730 DOI: 10.3390/cancers14040980] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 8 |
Chang JW, Jung DH, Huh CW, Park JC, Shin SK, Lee SK, Lee YC. Long-Term Outcomes and Prognostic Factors of Superficial Esophageal Cancer in Patients Aged ≥ 65 Years. Front Med 2022;8:722141. [DOI: 10.3389/fmed.2021.722141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
吴 晨. The Research Progress of Photodynamic Therapy for Superficial Esophageal Carcinoma. ACM 2022;12:12123-12129. [DOI: 10.12677/acm.2022.12121747] [Reference Citation Analysis]
|
| 10 |
Wang X, Hobbs B, Gandhi SJ, Muijs CT, Langendijk JA, Lin SH. Current status and application of proton therapy for esophageal cancer. Radiother Oncol 2021;164:27-36. [PMID: 34534613 DOI: 10.1016/j.radonc.2021.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 11 |
Yang H, Hu B. Recent advances in early esophageal cancer: diagnosis and treatment based on endoscopy. Postgrad Med 2021;133:665-73. [PMID: 34030580 DOI: 10.1080/00325481.2021.1934495] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 12 |
Yu J, Hu W, Yao N, Sun M, Li X, Wang L, Yang Y, Li B. Development and validation of a nomogram to predict overall survival of T1 esophageal squamous cell carcinoma patients with lymph node metastasis. Transl Oncol 2021;14:101127. [PMID: 34020370 DOI: 10.1016/j.tranon.2021.101127] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 13 |
Zhao W, Zhao J, Kang L, Li C, Xu Z, Li J, Zhang M. Fluoroscopy-Guided Salvage Photodynamic Therapy Combined with Nanoparticle Albumin-Bound Paclitaxel for Locally Advanced Esophageal Cancer after Chemoradiotherapy: A Case Report and Literature Review. Cancer Biother Radiopharm 2021. [PMID: 33794100 DOI: 10.1089/cbr.2020.4595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 14 |
Wu X, Zhang H, Sui Z, Wang Y, Yu Z. The biological role of the CXCL12/CXCR4 axis in esophageal squamous cell carcinoma. Cancer Biol Med 2021:j. [PMID: 33710803 DOI: 10.20892/j.issn.2095-3941.2020.0140] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 15 |
Sundaram S, Sharma P, Desai M. Endoscopic Mucosal Resection for Early Esophageal and Gastric Cancers. Innovations in Gastrointestinal Endoscopy 2021. [DOI: 10.1007/978-981-15-9247-8_12] [Reference Citation Analysis]
|
| 16 |
Badgery H, Read M, Winter NN, Taylor ACF, Hii MW. The role of esophagectomy in the management of Barrett's esophagus with high-grade dysplasia. Ann N Y Acad Sci 2020;1481:72-89. [PMID: 32812261 DOI: 10.1111/nyas.14439] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 17 |
Kim SH, Choi YS, Lee SK, Oh H, Choi SH. Comparison of general anesthesia and conscious sedation in procedure-related complications during esophageal endoscopic submucosal dissection. Surg Endosc 2020;34:3560-6. [PMID: 32468261 DOI: 10.1007/s00464-020-07663-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 18 |
Dix O, Thakur M, Genova A. Increased Risk of Esophageal Cancers Among Men in Taiwan. Cureus 2020;12:e6990. [PMID: 32201667 DOI: 10.7759/cureus.6990] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 19 |
Chon S, Bartella I, Bürger M. Endoskopische Therapieoptionen beim Adenokarzinom am ösophagogastralen Übergang. Onkologe 2019;25:1073-1079. [DOI: 10.1007/s00761-019-00673-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 20 |
Spataro J, Zfass AM, Schubert M, Shah T. Early Esophageal Cancer: A Gastroenterologist's Disease. Dig Dis Sci 2019;64:3048-58. [PMID: 31471859 DOI: 10.1007/s10620-019-05817-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 21 |
Zhao J, Lei J, Yu J, Zhang C, Song X, Zhang N, Wang Y, Zhang S. Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma. Invest New Drugs 2020;38:500-6. [PMID: 31650447 DOI: 10.1007/s10637-019-00866-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
|
